Kleanthis G. Xanthopoulos

Kleanthis Gabriel Xanthopoulos, Ph.D., is a seasoned executive in the biotechnology and healthcare sectors, currently serving as Chairman of the Board and CEO at Shoreline Biosciences, Inc. since June 2020. Concurrently, Xanthopoulos holds board positions at Connect Biopharma and Zosano Pharma, and serves as Chairman at Stork Capital Life Sciences. As a co-founder and board member of Sente Labs, a science-based cosmetics company, Xanthopoulos integrates innovative skincare solutions. Formerly, Xanthopoulos led IRRAS AB as CEO and was a Managing General Partner at Cerus DMCC. With an extensive academic background, including a Ph.D. in Molecular Biology from The Rockefeller University, Xanthopoulos has held leadership roles in various companies, driving advancements in therapeutics and healthcare solutions.